Literature DB >> 8996099

Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220.

J I Ross1, E A Eady, J H Cove, S Baumberg.   

Abstract

Previous studies have suggested that inducible erythromycin (Er) resistance in staphylococci mediated by the plasmid-borne ABC-transporter msrA is dependent on additional unidentified chromosomally encoded transmembrane (TM) domains. The requirement for two S. aureus candidate sequences, stpC and smpC, highly similar to sequences adjacent to msrA on the original S. epidermidis plasmid was investigated. Deletion of the sequences by allelic replacement was accomplished by electroporation of S. aureus RN4220 with a nonreplicating suicide vector. S. aureus strains carrying a delta(stpC-smpC) mutation showed an identical ErR phenotype to those arising from single crossover events and unmutated RN4220 containing msrA. This proves that neither stpC nor smpC is required for ErR. To further define the minimal functional unit required for MSR, the control region within the leader sequence of msrA was deleted. This resulted in constitutive resistance to Er and type B streptogramins (Sg), proving that SgR does not require the presence of Er. Deletion constructs containing the N- or C-terminal ABC regions of MsrA did not confer ErR in RN4220 singly or in combination.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8996099     DOI: 10.1016/s0378-1119(96)00541-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Putative ABC transporter responsible for acetic acid resistance in Acetobacter aceti.

Authors:  Shigeru Nakano; Masahiro Fukaya; Sueharu Horinouchi
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

3.  The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureus.

Authors:  Que Chi Truong-Bolduc; David C Hooper
Journal:  J Bacteriol       Date:  2007-02-02       Impact factor: 3.490

4.  Molecular analysis of resistance to streptogramin A compounds conferred by the Vga proteins of staphylococci.

Authors:  Olivier Chesneau; Heidi Ligeret; Negin Hosan-Aghaie; Anne Morvan; Elie Dassa
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  A new evolutionary variant of the streptogramin A resistance protein, Vga(A)LC, from Staphylococcus haemolyticus with shifted substrate specificity towards lincosamides.

Authors:  G Novotna; J Janata
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

6.  Regulation of expression of abcA and its response to environmental conditions.

Authors:  Regis A Villet; Que Chi Truong-Bolduc; Yin Wang; Zoe Estabrooks; Heidi Medeiros; David C Hooper
Journal:  J Bacteriol       Date:  2014-02-07       Impact factor: 3.490

7.  Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible.

Authors:  Karita D Ambrose; Rebecca Nisbet; David S Stephens
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

8.  MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus.

Authors:  Q C Truong-Bolduc; P M Dunman; J Strahilevitz; S J Projan; D C Hooper
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

Review 9.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

Review 10.  Efflux-mediated drug resistance in bacteria.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.